Jacobson was involved in the most comprehensive long-term study of whether hypoglycemia adversely impacts brain function. As part of a team Jacobson studied the effects of improved blood sugar control on type 1 diabetic patients who were participants in The Diabetes Control and Complications Trial—or DCCT. Read more
Lifebringer is a free, interactive web-based app for type 1 and 2 diabetics, as well as newly diagnosed diabetics, that goes beyond simply tracking blood sugars and organizing numbers input users. It also uses Meehan’s program, called Nagbot, to interact with the user. Nagbot sends encouraging emails to the user over their computer, tablet, or mobile device reminding them to test, or letting them know how they’re doing, and suggesting ways to improve their health. Nagbot, in other words, acts as a helpful companion. Read more
Good news on the blood glucose meter accuracy front: the Diabetes Technology Society (DTS) is beginning work on a surveillance program to ensure that blood glucose meters and strips that have been cleared for sale in the United States continue to meet those accuracy standards even after they’re on the market. Read more
That’s why when I heard about Casey Steffen’s HbA1c teaching model, I was instantly intrigued. It is a scientific model of a HbA1c protein that is tangible so people with diabetes and health care professionals can see what protein glycation looks like. This description made me want to learn more, so I spoke with Steffen, who demonstrated a great deal of passion in launching this diabetes education crowdfunding initiative. Read more
My husband found a case study about a boy diagnosed with type 1 diabetes in Denmark who had gone on a gluten-free diet after diagnosis and, sixteen months in, had an A1C of below six percent, with no daily insulin therapy. Read more
Akhila Satish, a public health advocate who has earned a master’s degree in biotechnology and built a company before hitting her quarter-life crisis, sees a way to a healthier society.
She has built Patient Partner, a mobile app based on a series of multiple-choice questions. It’s structured like a choose your own adventure game. Read more
It’s difficult to make the FDA’s new guidance on blood glucose test strips sound sexy, but I’m going to try. Imagine this situation: you’re sitting in front of a fire with your boyfriend/girlfriend/spouse/lover/partner, relaxing on some soft cushions or maybe a bearskin rug. The lights are low. Candles twinkle. Wine glasses are… Read more
When it came to using the data the Dexcom CGM was giving me on my blood sugar levels, the first day was a self-induced roller coaster nightmare. What left me feeling so anxious wasn’t actually the number on the screen or the programmed alarms I’d been advised by three experienced, certified diabetes educators to set at 75 mg/dL and 140 mg/dL. Instead, it was the arrows. Read more
CMS recently rolled out competitive bidding for glucose test strips, a highly controversial process which set the reimbursement amounts that Medicare is willing to pay for glucose test strips. These new prices went into effect on July 1, 2013. You can read Medicare’s summary of the changes here; as the New York Times reported (in a poorly researched article that does not acknowledge any potential quality or safety issues), whereas Medicare used to pay $77.90 for 100 test strips, it now will pay $22.47 – a 72% reduction. Read more
Yesterday I had the chance to visit the Philadelphia headquarters of Echo Therapeutics, a small company working to develop a new non-invasive — that is, totally needle-free — continuous glucose monitoring system called the Symphony CGM.